JFG
Jefferies Financial Group Portfolio holdings
AUM
$6.06B
This Quarter Return
+0.98%
1 Year Return
+9.37%
3 Year Return
+16.02%
5 Year Return
+51.04%
10 Year Return
+258.41%
AUM
$5.09B
AUM Growth
+$5.09B
(+2.8%)
Cap. Flow
+$257M
Cap. Flow
% of AUM
5.06%
Top 10 Holdings %
Top 10 Hldgs %
29.56%
Holding
1,608
New
306
Increased
296
Reduced
272
Closed
450
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$157M |
| 2 |
Golar LNG
GLNG
|
$94.9M |
| 3 |
Geron
GERN
|
$84.1M |
| 4 |
Boston Scientific
BSX
|
$49.9M |
| 5 |
AbbVie
ABBV
|
$37.1M |
Top Sells
| 1 |
SPDR S&P Biotech ETF
XBI
|
$70.5M |
| 2 |
argenx
ARGX
|
$58.1M |
| 3 |
NVIDIA
NVDA
|
$56.6M |
| 4 |
Delta Air Lines
DAL
|
$53M |
| 5 |
Moderna
MRNA
|
$45.7M |
Sector Composition
| 1 | Healthcare | 20.58% |
| 2 | Technology | 8.7% |
| 3 | Energy | 8.39% |
| 4 | Industrials | 7.09% |
| 5 | Consumer Discretionary | 6.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
DraftKings
DKNG
$23.7B
| $29.1M | 0.31% |
762,199
+15,500
| +2% | +$592K |
|
27
Vertex Pharmaceuticals
VRTX
$102B
| $28.3M | 0.3% |
60,275
+3,453
| +6% | +$1.62M |
|
|
TGI
28
DELISTED
Triumph Group
TGI
| $27.5M | 0.29% |
+1,786,019
| New | +$27.5M |
|
29
UnitedHealth
UNH
$279B
| $26.4M | 0.28% |
51,742
-1,018
| -2% | -$518K |
|
30
Berkshire Hathaway Class B
BRK.B
$1.08T
| $25.8M | 0.27% |
+63,425
| New | +$25.8M |
|
31
Amgen
AMGN
$153B
| $25.1M | 0.27% |
80,426
-3,080
| -4% | -$962K |
|
32
Johnson & Johnson
JNJ
$429B
| $24.2M | 0.26% |
165,250
-35,438
| -18% | -$5.18M |
|
33
Stryker
SYK
$149B
| $23.8M | 0.25% |
69,816
+18,868
| +37% | +$6.42M |
|
34
Amazon
AMZN
$2.41T
| $22.8M | 0.24% |
118,055
+53,518
| +83% | +$10.3M |
|
35
Sprinklr
CXM
$2B
| $22.7M | 0.24% |
+2,355,000
| New | +$22.7M |
|
36
Health Care Select Sector SPDR Fund
XLV
$33.8B
| $22.3M | 0.24% |
152,792
+22,816
| +18% | +$3.33M |
|
37
Exxon Mobil
XOM
$477B
| $22.2M | 0.24% |
192,926
-64,524
| -25% | -$7.43M |
|
38
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.7B
| $22.2M | 0.24% |
287,520
+280,620
| +4,067% | +$21.6M |
|
39
Chevron
CVX
$318B
| $22.1M | 0.24% |
141,490
-106,594
| -43% | -$16.7M |
|
40
Gilead Sciences
GILD
$140B
| $22M | 0.23% |
320,795
-110,927
| -26% | -$7.61M |
|
41
Regeneron Pharmaceuticals
REGN
$59.8B
| $21.5M | 0.23% |
20,491
+11,851
| +137% | +$12.5M |
|
42
Texas Instruments
TXN
$178B
| $21.3M | 0.23% |
109,342
+53,813
| +97% | +$10.5M |
|
43
Range Resources
RRC
$8.18B
| $21.2M | 0.23% |
632,431
+118,287
| +23% | +$3.97M |
|
44
Zoetis
ZTS
$67.6B
| $20.9M | 0.22% |
120,538
+101,206
| +524% | +$17.5M |
|
45
Alphabet (Google) Class C
GOOG
$2.79T
| $20.6M | 0.22% |
112,305
+108,185
| +2,626% | +$19.8M |
|
46
Invesco S&P 500 Equal Weight ETF
RSP
$73.5B
| $20.4M | 0.22% |
124,158
+2,149
| +2% | +$353K |
|
47
Oracle
ORCL
$628B
| $19.3M | 0.21% |
136,647
+126,947
| +1,309% | +$17.9M |
|
48
Freeport-McMoran
FCX
$66.3B
| $19M | 0.2% |
389,931
+300,293
| +335% | +$14.6M |
|
|
CTLT
49
DELISTED
CATALENT, INC.
CTLT
| $18.9M | 0.2% |
336,868
-29,431
| -8% | -$1.65M |
|
50
International Paper
IP
$25.4B
| $18.2M | 0.19% |
+422,743
| New | +$18.2M |
|